Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol in obstructive sleep apnea
NCT01755091Phase 2Completed
- Sponsor
- University of Illinois Chicago
- Start
- Feb 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in obstructive sleep apnea (OSA), sponsored by University of Illinois Chicago. Started Feb 2013; status: completed.
02
Drugs
dronabinol
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01755091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755091.